Price
Financials
Standalone, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 84 | 76 | 81 | 100 | 102 | 95 | 100 | 117 | 118 | 116 | 120 | 143 |
| Expenses | 61 | 55 | 56 | 69 | 72 | 69 | 68 | 80 | 78 | 82 | 86 | 100 |
| Operating Profit | 23 | 21 | 24 | 31 | 30 | 26 | 32 | 37 | 40 | 34 | 34 | 43 |
| OPM % | 28% | 27% | 30% | 31% | 29% | 27% | 32% | 32% | 34% | 30% | 28% | 30% |
| Other Income | 1 | 1 | 2 | 0 | 2 | 2 | 0 | 1 | 1 | 3 | 2 | 2 |
| Interest | 2 | 2 | 2 | 3 | 4 | 4 | 3 | 4 | 4 | 2 | 2 | 3 |
| Depreciation | 6 | 7 | 8 | 10 | 9 | 10 | 10 | 11 | 11 | 12 | 12 | 11 |
| Profit before tax | 17 | 13 | 17 | 19 | 19 | 14 | 19 | 23 | 26 | 23 | 21 | 31 |
| Tax % | 24% | 26% | 26% | 25% | 26% | 26% | 14% | 26% | 25% | 26% | 24% | 24% |
| Net Profit | 13 | 9 | 13 | 14 | 14 | 10 | 16 | 17 | 19 | 17 | 16 | 23 |
| EPS in Rs | 26.79 | 20.09 | 27.21 | 30.02 | 30.11 | 22.13 | 34.02 | 36.72 | 39.98 | 35.76 | 33.60 | 48.38 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 137 | 149 | 153 | 170 | 176 | 140 | 201 | 268 | 319 | 397 | 471 | 497 |
| Expenses | 119 | 126 | 129 | 140 | 129 | 109 | 143 | 192 | 227 | 277 | 324 | 345 |
| Operating Profit | 18 | 23 | 24 | 30 | 47 | 31 | 59 | 76 | 92 | 120 | 147 | 151 |
| OPM % | 13% | 15% | 16% | 18% | 27% | 22% | 29% | 28% | 29% | 30% | 31% | 30% |
| Other Income | -5 | 1 | 2 | 2 | 3 | 1 | 1 | 2 | 5 | 5 | 6 | 7 |
| Interest | 5 | 4 | 3 | 4 | 9 | 7 | 7 | 8 | 8 | 15 | 14 | 10 |
| Depreciation | 9 | 9 | 10 | 11 | 21 | 19 | 20 | 20 | 27 | 39 | 46 | 47 |
| Profit before tax | -0 | 11 | 13 | 17 | 20 | 6 | 32 | 49 | 62 | 71 | 94 | 101 |
| Tax % | -104% | 33% | 49% | 32% | 31% | 125% | 25% | 25% | 26% | 23% | 25% | |
| Net Profit | 0 | 7 | 7 | 12 | 14 | -1 | 24 | 37 | 46 | 55 | 70 | 76 |
| EPS in Rs | 0.09 | 15.62 | 14.43 | 25.36 | 29.11 | -3.06 | 51.28 | 78.55 | 98.64 | 116.28 | 145.05 | 157.72 |
| Dividend Payout % | 940% | 10% | 8% | 6% | -0% | -0% | 6% | 4% | 3% | 5% | 5% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 13% | 27% | 21% | 20% | ||
| Compounded Profit Growth | 35% | 118% | 22% | 32% | ||
| Stock Price CAGR | 40% | 67% | 29% | 6% | ||
| Return on Equity | 28% | 30% | 28% | 24% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | 19 | 19 | 25 | 30 | 41 | 51 | 50 | 73 | 109 | 152 | 205 | 341 |
| Borrowings | 27 | 31 | 23 | 18 | 24 | 60 | 68 | 193 | 232 | 268 | 333 | 326 |
| Other Liabilities | 18 | 24 | 20 | 28 | 31 | 24 | 33 | 42 | 44 | 71 | 71 | 94 |
| Total Liabilities | 69 | 79 | 72 | 81 | 100 | 141 | 155 | 314 | 390 | 496 | 613 | 766 |
| Fixed Assets | 26 | 34 | 33 | 36 | 55 | 94 | 96 | 214 | 260 | 316 | 393 | 403 |
| CWIP | 0 | 1 | 1 | 3 | 0 | 0 | -0 | 26 | 62 | 97 | 128 | 197 |
| Investments | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 13 | 89 |
| Other Assets | 43 | 44 | 38 | 42 | 45 | 47 | 60 | 73 | 67 | 83 | 80 | 78 |
| Total Assets | 69 | 79 | 72 | 81 | 100 | 141 | 155 | 314 | 390 | 496 | 613 | 766 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 14 | 17 | 20 | 19 | 25 | 39 | 34 | 57 | 70 | 90 | 94 | 145 |
| Cash from Investing Activity | -10 | -17 | -8 | -11 | -25 | -17 | -11 | -46 | -71 | -70 | -133 | -174 |
| Cash from Financing Activity | -5 | -0 | -12 | -8 | 2 | -20 | -8 | -4 | 0 | -14 | 17 | 25 |
| Net Cash Flow | -1 | 0 | 0 | -0 | 2 | 2 | 15 | 7 | -1 | 6 | -23 | -4 |
| Free Cash Flow | 3 | 1 | 12 | 7 | 0 | 22 | 23 | 10 | -1 | 19 | -9 | 47 |
| CFO/OP | 106% | 113% | 103% | 98% | 111% | 96% | 120% | 112% | 107% | 112% | 95% | 105% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 19 | 24 | 16 | 17 | 19 | 14 | 23 | 16 | 14 | 15 | 13 | 14 |
| Inventory Days | 238 | 200 | 123 | 148 | 124 | 132 | 117 | 91 | 73 | 106 | 55 | 51 |
| Days Payable | 360 | 371 | 277 | 353 | 292 | 224 | 401 | 410 | 327 | 345 | 101 | 97 |
| Cash Conversion Cycle | -103 | -146 | -138 | -189 | -149 | -78 | -260 | -303 | -240 | -224 | -34 | -31 |
| Working Capital Days | -31 | -39 | -25 | -39 | -22 | -34 | -70 | -58 | -50 | -63 | -51 | -55 |
| ROCE % | 19% | 18% | 29% | 32% | 34% | 30% | 11% | 20% | 19% | 18% | 18% | 17% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 71.89% | 71.89% | 71.89% | 71.90% | 71.90% | 71.90% | 71.90% | 71.90% | 72.67% | 72.67% | 72.67% | 72.67% |
| FIIs | 0.28% | 0.63% | 0.64% | 0.65% | 0.83% | 0.84% | 1.33% | 1.49% | 1.74% | 1.82% | 2.20% | 2.24% |
| DIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.96% | 1.04% | 1.95% | 2.31% | 2.36% | 2.36% | 2.12% | 2.05% |
| Public | 27.82% | 27.47% | 27.47% | 27.46% | 26.32% | 26.22% | 24.82% | 24.29% | 23.22% | 23.15% | 22.99% | 23.03% |
| No. of Shareholders | 3,471 | 3,423 | 3,572 | 3,808 | 4,510 | 15,115 | 41,704 | 35,976 | 30,528 | 25,449 | 24,036 | 22,954 |
Fundamentals
Market Cap₹ 2,482 Cr.
Current Price₹ 5,130
Stock P/E32.6
Book Value₹ 717
ROCE17.2 %
ROE24.2 %
Dividend Yield0.14 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)20%
Compounded Profit Growth (TTM)32%
Standalone figures.
Valuation
Market capRs 2,493 Cr
Enterprise valueRs 2,813 Cr
P/E (TTM)32.71x
Price to book7.20x
Price to sales5.02x
EV / EBITDA17.75x
EV / EBIT25.14x
EV / sales5.66x
Price to cash flow17.18x
Earnings yield3.06%
Dividend yield0.14%
P/E, 3-year average32.90x
P/B, 3-year average8.31x
P/E, 5-year average24.92x
P/B, 5-year average6.62x
Profitability
Operating margin (excl. other income)31.22%
Operating margin (incl. other income)32.46%
EBITDA margin31.88%
Pre-tax margin20.40%
Net profit margin15.34%
Net margin, latest quarter16.35%
ROE25.22%
ROCE17.64%
ROA10.16%
ROE, 3-year average29.77%
ROCE, 3-year average17.87%
ROA, 3-year average10.16%
ROE, 5-year average32.83%
ROCE, 5-year average18.46%
ROA, 5-year average10.25%
ROIC (approx.)12.58%
Tax rate25.11%
Other income / net worth1.68%
Growth
Sales growth (latest year)18.56%
Profit growth (latest year)28.27%
Sales CAGR, 3 years20.65%
Sales CAGR, 5 years27.49%
Profit CAGR, 3 years23.83%
Sales growth QoQ19.13%
Profit growth QoQ43.97%
Sales growth YoY (latest quarter)22.28%
Profit growth YoY (latest quarter)35.46%
Per share
EPS (TTM)Rs 157.71
EPS (latest year)Rs 145.05
EPS (latest quarter)Rs 48.38
EPS, 3-year averageRs 119.99
EPS, 5-year averageRs 97.96
Book value per shareRs 716.56
Sales per shareRs 1,028.22
Cash flow per shareRs 300.32
Free cash flow per shareRs 97.25
Dividend per share (latest year)Rs 6.99
Dividend per share, 3-year averageRs 5.17
Dividend per share, 5-year averageRs 4.30
Dividends
Dividend payout4.82%
Dividend payout, 3-year average4.18%
Dividend payout, 5-year average4.44%
Efficiency
Asset turnover0.61x
Fixed asset turnover1.17x
Inventory turnover8.86x
Inventory days41 days
Debtor days15 days
Debtors turnover25.17x
Creditor days97 days
Cash conversion cycle-31 days
Working capital days-55 days
Leverage
Total debtRs 326 Cr
Cash and bankRs 7 Cr
Net debtRs 319 Cr
Debt to equity0.94x
Net debt / EBITDA2.02x
Interest coverage10.66x
Owners' fund to total sources45.18%
Debt to assets42.55%
Cash flow
Cash from Operating Activity (latest year)Rs 145 Cr
Cash from Investing Activity (latest year)Rs -174 Cr
Cash from Financing Activity (latest year)Rs 25 Cr
Net Cash Flow (latest year)Rs -4 Cr
Free cash flow (latest year)Rs 47 Cr
FCFE (approx.: FCF + change in debt)Rs 40 Cr
Cash from ops / profit, 5 years1.97x
Sales to cash flow3.24x
Statement figures
Net sales (TTM)Rs 497 Cr
Net sales (latest year)Rs 471 Cr
Sales (latest quarter)Rs 143 Cr
Operating profit excl. other income (latest year)Rs 147 Cr
Operating profit (latest quarter)Rs 43 Cr
Other income (TTM)Rs 7 Cr
EBITDA (TTM)Rs 158 Cr
PBDT (TTM)Rs 148 Cr
Profit before tax (TTM)Rs 101 Cr
Tax (latest year)Rs 24 Cr
Net profit (TTM)Rs 76 Cr
Net profit (latest year)Rs 70 Cr
Net profit (latest quarter)Rs 23 Cr
Depreciation (TTM)Rs 47 Cr
Depreciation (latest quarter)Rs 11 Cr
Interest (TTM)Rs 10 Cr
Cost of goods sold (latest year)Rs 125 Cr
Total expenditure (latest year)Rs 324 Cr
Total income (latest year)Rs 477 Cr
Share capitalRs 5 Cr
ReservesRs 341 Cr
Shareholders' fundsRs 346 Cr
Total assetsRs 766 Cr
Net blockRs 403 Cr
Capital work in progressRs 197 Cr
InvestmentsRs 89 Cr
ReceivablesRs 19 Cr
InventoryRs 14 Cr
Other liabilitiesRs 94 Cr
Shares outstanding (crore)0.48
Ownership
Promoter holding72.67% (+0.77 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 32.7 is at the 54th percentile of its own 8.4-year range
(median 29.2, low 7.3, high 62.6).
P/B 7.20 is at the 55th percentile (median 6.97).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | DRAGARWQ | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | +0.0% | -2.8% | +2.8 pts |
| 1 month | -2.8% | -6.8% | +4.0 pts |
| 3 months | +2.6% | -7.6% | +10.2 pts |
| 3 years | +117.3% | +14.2% | +103.1 pts |
| 5 years | +1195.7% | +27.9% | +1167.9 pts |
4 mutual fund schemes hold about ₹2 Cr.
Over three months 2 bought more and 0 sold (share counts, price move removed).
| Fund | Weight | Est. Cr | 3m shares |
|---|---|---|---|
| PGIM India Healthcare Fund | 1.20% | 2 | +138% |
| PGIM India Retirement Fund | 0.21% | 0 | -5% |
| PGIM India Small Cap Fund | 0.01% | 0 | +100% |
| Bandhan BSE Healthcare Index Fund | 0.04% | 0 | -3% |
Red flags
F-score 6 of 8No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹143 Cr +22.2% vs Jun 2025.
Net profit ₹23 Cr +35.3%.
Against our estimate for Jun 2026: sales +1.0%, profit +11.3% beat. Our estimate for Sep 2026: sales Rs 143 Cr, profit Rs 22 Cr (how).
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Apollo Hospitals Enterprise Ltd | 124,503 | 59.2 | 17.4 % |
| Manipal Health Enterprises Ltd | 98,357 | 111 | 12.1 % |
| Max Healthcare Institute Ltd | 95,589 | 63.8 | 14.7 % |
| Aster DM Quality Care Ltd | 63,976 | 177 | 11.6 % |
| Fortis Healthcare Ltd | 62,058 | 58.2 | 13.4 % |
| Global Health Ltd | 38,048 | 66.4 | 17.4 % |
| Narayana Hrudayalaya Ltd | 36,579 | 42.4 | 15.5 % |
| Krishna Institute of Medical Sciences Ltd | 32,336 | 155 | 9.50 % |
| Dr Agarwals Health Care Ltd | 15,701 | 106 | 10.9 % |
| Rainbow Childrens Medicare Ltd | 13,892 | 48.5 | 17.4 % |
| Park Medi World Ltd | 11,898 | 42.8 | 19.5 % |
| Yatharth Hospital & Trauma Care Services Ltd | 10,676 | 58.9 | 12.9 % |
| Healthcare Global Enterprises Ltd | 10,505 | 218 | 8.30 % |
| Jupiter Life Line Hospitals Ltd | 8,591 | 44.9 | 14.8 % |
| Kovai Medical Center & Hospital Ltd | 6,579 | 25.7 | 22.6 % |
No bulk or block deals on record.
| Ex-date | Action | Factor |
|---|---|---|
| 2026-09-02 | Dividend - Rs 4 Per Share |
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Less than 100 unique PAN traded in previous 30 days
Quick answers
What is the market cap of Dr Agarwals Eye Hospital Ltd?
Dr Agarwals Eye Hospital Ltd (DRAGARWQ) has a market capitalisation of Rs 2,482 Cr. at the 2026-10-01 close.
What is the P/E ratio of Dr Agarwals Eye Hospital Ltd?
Dr Agarwals Eye Hospital Ltd trades at a P/E of 32.6 on trailing twelve-month profit, at the 2026-10-01 close.
What were Dr Agarwals Eye Hospital Ltd's latest quarterly results?
In the Jun 2026 quarter, Dr Agarwals Eye Hospital Ltd sales was Rs 143 Cr (+22.2% vs Jun 2025) and net profit was Rs 23 Cr.
What is the 52-week high and low of Dr Agarwals Eye Hospital Ltd?
The 52-week high is Rs 6,059.70 and the 52-week low is Rs 4,600.00.